Specific immunotherapy prevents increased levels of allergen-specific IL-4- and IL-13-producing cells during pollen season (Q56827955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Specific immunotherapy prevents increased levels of allergen-specific IL-4- and IL-13-producing cells during pollen season (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Marita Troye-Blomberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Söderlund

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Paulie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T C van der Pouw Kraan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Rak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

293-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

Allergen-controlled study of intranasal immunotherapy for ragweed hay fever

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Increased Frequencies of Allergen-Induced Interleukin-13-Producing Cells in Atopic Individuals During the Pollen Season

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Specific induction of interleukin-4-producing cells in response to in vitro allergen stimulation in atopic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

The influence of cryopreservation on cytokine production by human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Role of IL-13 in CD4 T cell-dependent IgE production in atopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Decrease of allergen-specific T-cell response induced by local nasal immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Modulation of T-cell response to phospholipase A2 and phospholipase A2–derived peptides by conventional bee venom immunotherapy☆☆☆★★★

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

Local intranasal immunotherapy for ragweed allergic rhinitis I. Clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Nasal Immunotherapy in Weed-Induced Allergic Rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Immunotherapy in Atopic Allergy – Antibody Titres and Avidities during Hyposensitization with Birch and Timothy Pollen Allergens

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Immunologic changes associated with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Grass immunotherapy induces inhibition of allergen-specific human peripheral blood mononuclear cell proliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Immunotherapy Affects the Seasonal Increase in Specific IgE and Interleukin‐4 in Serum of Patients with Seasonal Allergic Rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Immunotherapy suppresses both Th1 and Th2 responses by allergen stimulation, but suppression of the Th2 response is a more important mechanism related to the clinical efficacy of immunotherapy for perennial allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Expression of Lymphocytes FcεRII/CD23 in Allergic Children Undergoing Hyposensitization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Decrease in CD23+ B lymphocytes and clinical outcome in asthmatic patients receiving specific rush immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-gamma) in peripheral blood mononuclear cells (PBMC) from atopic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Clonal diversity of IL-4 and IL-13 expression in human allergen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

Modified T-cell activation pattern during specific immunotherapy (SIT) in cat-allergic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00472.X

7 January 2021

10.1034/J.1398-9995.2001.00472.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11284795%20AND%20SRC:MED&resulttype=core&format=json